Database of veterinary systematic reviews
PLoS Negl Trop Dis (2019) 13: e0007182
DOI: 10.1371/journal.pntd.0007182
BACKGROUND: Scabies is a common dermatological condition, affecting more than 130 million people at any time. To evaluate and/or predict the effectiveness and cost-effectiveness of scabies interventions, disease transmission modelling can be used. OBJECTIVE: To review published scabies models and data to inform the design of a comprehensive scabies transmission modelling framework to evaluate the cost-effectiveness of scabies interventions. METHODS: Systematic literature search in PubMed, Medline, Embase, CINAHL, and the Cochrane Library identified scabies studies published since the year 2000. Selected papers included modelling studies and studies on the life cycle of scabies mites, patient quality of life and resource use. Reference lists of reviews were used to identify any papers missed through the search strategy. Strengths and limitations of identified scabies models were evaluated and used to design a modelling framework. Potential model inputs were identified and discussed. FINDINGS: Four scabies models were published: a Markov decision tree, two compartmental models, and an agent-based, network-dependent Monte Carlo model. None of the models specifically addressed crusted scabies, which is associated with high morbidity, mortality, and increased transmission. There is a lack of reliable, comprehensive information about scabies biology and the impact this disease has on patients and society. DISCUSSION: Clinicians and health economists working in the field of scabies are encouraged to use the current review to inform disease transmission modelling and economic evaluations on interventions against scabies.
van der Linden, N., van Gool, K., Gardner, K., Dickinson, H., Agostino, J., Regan, D. G., Dowden, M., & Viney, R. (2019). A systematic review of scabies transmission models and data to evaluate the cost-effectiveness of scabies interventions. PLoS Negl Trop Dis, 13(3), e0007182. https://doi.org/10.1371/journal.pntd.0007182 Animals, Humans, Monte Carlo Method, *Cost-Benefit Analysis, Antiparasitic Agents/economics/therapeutic use, Decision Trees, Ivermectin/economics/therapeutic use, Life Cycle Stages/drug effects/physiology, Quality-Adjusted Life Years, Sarcoptes scabiei/drug effects/*growth & development/physiology, Scabies/drug therapy/*economics/mortality/*transmission